Work Here?
IPS-Integrated Project Services, LLC
Work Here?
Integrated design, engineering, construction management
IPS-Integrated Project Services, LLC
Work Here?
Integrated design, engineering, construction management
Overview
IPS provides design, engineering, and construction management for complex facilities, especially in the pharmaceutical and biotech industries. Its products work by integrating these services into one team from the project’s start, coordinating planning, detailed design, procurement, and construction management to align with a client's business goals and move a project from concept to operational facility. The company differentiates itself through integrated delivery across disciplines and a global footprint (five continents), supported by growth through strategic acquisitions and Berkshire Hathaway backing, which adds financial strength and scale. IPS’s goal is to help life-science clients bring critical facilities online efficiently, with predictable cost, schedule, and quality, by delivering coordinated design, engineering, and construction management under one umbrella.
About IPS-Integrated Project Services, LLC
Industries
Consulting
Industrial & Manufacturing
Biotechnology
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Philadelphia, Pennsylvania
Founded
1989
Get referred to IPS-Integrated Project Services, LLC
See people who can refer or advise you
Simplify's Take
What believers are saying
- GE HealthCare named IPS lead on its Cork expansion on January 31, 2025.
- BeiGene's $800 million Hopewell facility completed in January 2025, proving delivery at scale.
- Revelio Labs showed 7,131 employees in March 2026, with 561 active postings across the business.
What critics are saying
- Kinetic System v. IPS ended with adverse fee rulings on March 24, 2025, exposing contract friction.
- IPS remains tied to capital-intensive drug plants; project cancellations quickly crush utilization and margin.
- If biotech capex freezes through 2026, IPS loses backlog concentration and Berkshire owns a cyclical builder.
What makes IPS-Integrated Project Services, LLC unique
- IPS integrates EPCMV across pharma and biotech, from concept through final process qualification.
- Berkshire Hathaway ownership since 2022 gives IPS permanent capital and credibility with large customers.
- IPS runs 29 offices across 22 countries, supporting global delivery for regulated facilities.
Help us improve and share your feedback! Did you find this helpful?
Growth & Insights and Company News
6 month growth
↑ 12%1 year growth
↑ 12%2 year growth
↑ 12%TACOMA, Wash., Aug. 7, 2025 /PRNewswire/ - AST is pleased to announce that Jacob Stephen will be joining the AST Team as Chief Operations Officer at the Tacoma-headquartered drug product equipment manufacturing company.
IPS expands leadership in Ireland with appointment of Karl Page.
Sai Bhamidipati, Pharmaceutical Regulatory Affairs ConsultantThe biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities to address complex diseases. Yet, they also present unique regulatory and manufacturing challenges that must be navigated to bring them from the laboratory to the clinic.mRNA Vaccines: Revolutionizing Disease PreventionMessenger RNA (mRNA) vaccines have gained prominence, particularly during the COVID-19 pandemic, demonstrating the potential for rapid development and high efficacy. Unlike traditional vaccines, which utilize weakened or inactivated pathogens or their protein subunits, mRNA vaccines utilize a synthetic version of the messenger RNA to instruct cells to produce a protein that elicits an immune response. This modality allows for swift adaptation to emerging pathogens and has opened avenues for vaccines targeting various diseases, including influenza and certain types of cancers.Opportunities:Rapid Development: The cell-free, scalable nature of mRNA production enables quick responses to emerging health threats.IPSDBThe cell-free, scalable nature of mRNA production enables quick responses to emerging health threats. IPSDB Versatility: mRNA vaccines can be designed to target a wide range of therapeutic areas, including but not limited to infectious diseases, Cancer-specific antigens, and rare disease areas.Challenges:Manufacturing Complexities: Scaling up production for mass production while maintaining quality and consistency poses significant challenges
By integrating Kneat's digital validation software with IPS' technology driven delivery approach, a new benchmark for a truly digital integrated project delivery model, from concept/requirements definition through final process qualification.
Additionally, Integrated Project Services, LLC is excited to announce the appointment of Pia Mueller as the new Senior Manager of Laboratory Projects.
IPS-Integrated Project Services, LLC is Hiring for 164 Jobs on Simplify!
Find jobs on Simplify and start your career today
About IPS-Integrated Project Services, LLC
Industries
Consulting
Industrial & Manufacturing
Biotechnology
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Philadelphia, Pennsylvania
Founded
1989
IPS-Integrated Project Services, LLC is Hiring for 164 Jobs on Simplify!
Find jobs on Simplify and start your career today